Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04342637 · ClinicalTrials.gov registry record
COVID-19 Endoscopy Survey
A clinical trial of COVID-19, sponsored by Al-Azhar University.
- Completed
- Registry status
- 163
- Enrollment target
- 4
- Study locations
NCT04342637: Completed study of COVID-19, sponsored by Al-Azhar University.
NCT04342637 is a study of COVID-19 that has completed, run by Al-Azhar University. The registered enrollment target is 163 participants, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower). The trial reports 4 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04342637, a study of COVID-19, has completed, sponsored by Al-Azhar University.
- COMPLETED
- Registry status
- 163 participants
- Enrollment target
- 4
- Study locations
Study Summary
A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of GI endoscopy practice in the studied countries.
Primary Outcome
To evaluate the validity of different GI societies recommendations applied locally and how effective they are in preventing transmission in endoscopy units through reporting any new cases developing COVID-19 within two weeks of doing endoscopy (whether a patient or health-care worker)
Conditions Studied
Interventions
- OTHER Practice details
Study Locations (4)
Other
- Al-Azhar Univerisity - Cairo
- Ahvaz Imam hospital - Ahvāz
New York
- Kings County Hospital Center, Brooklyn, NY, USA - Albertson
Sharqia Province
- Faculty of Medicine, Zagazig University - Zagazig
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 163 participants |
| Start Date | 2020-04-10 |
| Est. Completion | 2020-05-01 |
What the finished NCT04342637 record still lists
NCT04342637 is an observational study that tracks outcomes without assigning an intervention. The registered 163 participants enrollment target is mid-sized for trials with a published cap, below the 38,464-participant average among 298 other COVID-19 trials with a reported enrollment target (100% lower).
The record links to 1 condition, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which Practice details is the first listed.
NCT04342637 reports a single indexed study location in Other, New York, Sharqia Province.
Frequently Asked Questions
What is clinical trial NCT04342637 about?
NCT04342637 is a clinical study titled "COVID-19 Endoscopy Survey". A questionnaire containing some critical questions about practice inside GI endoscopy units in different countries will be distributed via emails. Responses will be collected in an online platform and data will be analyzed to reveal the effect of SARS-CoV-2 pandemic on different aspects of GI endosc...
What is the current status of trial NCT04342637?
This trial is currently completed. The enrollment target is 163 participants. The study started on 2020-04-10. Estimated completion is 2020-05-01.
What conditions does trial NCT04342637 study?
This clinical trial studies the following conditions: COVID-19.
What interventions are being tested in trial NCT04342637?
The interventions under investigation include: Practice details (OTHER).
Who is sponsoring clinical trial NCT04342637?
This trial is sponsored by Al-Azhar University, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04342637 being conducted?
This trial has 4 study locations across New York, Sharqia Province. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04342637's enrollment target sits among peer trials
163 168th of 298 higher than 131 of 298 other COVID-19 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other COVID-19 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
The Impact of COVID-19 on Maternal and Neonatal Outcomes
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03180268 · 163 participants · Phase 3
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery
- NCT04862221 · 163 participants · Phase 2
TReatment for ImmUne Mediated PathopHysiology
- NCT05702229 · 163 participants · Phase 2
Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
- NCT06137118 · 163 participants · Phase 1
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI